Although the literature reports that CD109 is highly expressed in squamous cell carcinoma [13,20], our previous study identified that CD109 overexpression was specifically associated with poor survival probability in patients with lung adenocarcinoma but not with squamous cell carcinoma [12]. This evidence concerns the gene CD109 and lung adenocarcinoma.